AGP Executive Report
Last update: 2 hours agoMassHealth Fraud Fight: Massachusetts Attorney General Andrea Campbell sued UnitedHealthcare, alleging more than $100M in Medicaid fraud tied to patient misclassification, adding pressure to state oversight of managed care. Behavioral Health Spotlight: A Leadership Dialogue podcast highlighted how New England hospitals are trying to scale behavioral health capacity as demand rises and burnout spreads among caregivers. Cancer Pipeline (Vertex): Vertex said the FDA accepted its biologics license application for povetacicept in IgA nephropathy, setting a Nov. 30, 2026 action date. Cancer Pipeline (ASCO updates): Sumitomo Pharma America shared early clinical data on SMP-3124LP, a PEGylated liposome CHK1 inhibitor, while Convergent Therapeutics reported promising Phase 2 interim results for CONV01-α in Lu-PSMA-exposed metastatic prostate cancer. Public Health & Vaccines: A modeling study warns that shifting from universal hepatitis B birth-dose vaccination to targeted approaches could require much higher maternal screening or infant coverage to prevent neonatal infection increases. Local Health Policy: Massachusetts courts and probate leaders are piloting “rightsizing guardianship supports” via community mapping to expand less restrictive alternatives.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
